Bastian Patrick J, Hutterer Georg C, Shariat Shahrokh F, Rogers Craig G, Palapattu Ganesh S, Lotan Yair, Vazina Amnon, Amiel Gilad E, Gupta Amit, Sagalowsky Arthur I, Lerner Seth P, Schoenberg Mark P, Karakiewicz Pierre I
The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA.
BJU Int. 2008 Feb;101(4):450-4. doi: 10.1111/j.1464-410X.2007.07213.x. Epub 2007 Sep 10.
To examine whether the presence of microscopic (pT3a) or macroscopic (pT3b) disease worsens the prognosis relative to pT2 disease at radical cystectomy, as the prognostic significance of pT3a vs pT3b perivesical fat invasion (pT3) is controversial.
In all, 242 patients with pT3 disease (pT3a in 88, pT3b in 121) had radical cystectomy and bilateral pelvic lymphadenectomy for transitional cell carcinoma of the urinary bladder; they were compared with 172 who had organ-confined muscle-invasive disease (pT2). For the analyses we used univariable and multivariable Cox regression models of recurrence and cancer-specific survival, adjusted for age, tumour grade, lymphovascular invasion and the presence of lymph node metastases.
In multivariable analyses, microscopic perivesical fat extension (pT3a) was not associated with higher recurrence (P = 0.3) or the mortality rate (P = 0.06) vs pT2 disease. Conversely, the presence of deep perivesical fat extension (pT3b) was associated with 1.8 times the rate of recurrence (P = 0.002) and with twice the rate of death (P = 0.001) vs pT2 disease.
These findings imply that a detailed assessment of the cystectomy specimen for the presence of microscopic perivesical fat invasion might not be necessary, as the presence of pT3a disease has no strong effect on recurrence or mortality. Moreover, patients with pT3a disease might not require more aggressive therapy than their counterparts with pT2 disease. However, further validation of our data is required.
鉴于膀胱周围脂肪浸润的pT3a与pT3b(pT3)的预后意义存在争议,探讨在根治性膀胱切除术中,相对于pT2疾病,显微镜下(pT3a)或肉眼可见(pT3b)病变是否会使预后恶化。
共有242例患有pT3疾病(88例为pT3a,121例为pT3b)的患者因膀胱移行细胞癌接受了根治性膀胱切除术和双侧盆腔淋巴结清扫术;将他们与172例患有器官局限性肌层浸润性疾病(pT2)的患者进行比较。在分析中,我们使用了单变量和多变量Cox回归模型来分析复发情况和癌症特异性生存率,并对年龄、肿瘤分级、淋巴管浸润和淋巴结转移情况进行了校正。
在多变量分析中,与pT2疾病相比,显微镜下膀胱周围脂肪浸润(pT3a)与更高的复发率(P = 0.3)或死亡率(P = 0.06)无关。相反,与pT2疾病相比,膀胱周围深部脂肪浸润(pT3b)的存在与复发率增加1.8倍(P = 0.002)和死亡率增加两倍(P = 0.001)相关。
这些发现表明,由于pT3a疾病的存在对复发或死亡率没有强烈影响,因此可能无需对膀胱切除标本进行显微镜下膀胱周围脂肪浸润的详细评估。此外,患有pT3a疾病的患者可能不需要比患有pT2疾病的患者更积极的治疗。然而,我们的数据需要进一步验证。